Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07660120Not yet recruiting
Randomised, triple-blind trial of fluorouracil 5% cream in Hypertrophic Scar (HS) and burn injury (2 arms), sponsored by University of California, Davis. Primary endpoint: Patient and Observer Scar Assessment Scale Version 3.0 at 12 months. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07660120.